Competitiveness, Profitability and R/D Intensity: The Case of the Domestic Pharmaceutical Industry in Greece
Vasiliki Kounnou () and
Dimitrios Kyrkilis ()
Additional contact information
Vasiliki Kounnou: University of Macedonia
Dimitrios Kyrkilis: University of Macedonia
A chapter in Business Performance and Financial Institutions in Europe, 2020, pp 47-55 from Springer
Abstract Greek pharmaceutical industry has been emerged as one of the major drivers for the Greek manufacturing sector mostly from 2000 until 2011. The value-added of the industry in the overall economy is indicated through its impact on the gross value-added production, employment, exports, innovation and global competiveness. Greek pharmaceuticals firms have one of the highest shares of investment in innovation and R&D activities in the total Greek economy. The purpose of this study is to investigate the potential causal relationship between industry-level competitiveness, profitability and R/D intensity. Specific financial ratios have been selected for the regression analysis using a sample of Greek pharmaceutical firms with in-house Research and Development department. The period of the analysis has been defined between 2004 and 2015. According to the existing literature, it is expected that R/D intensity plays a significant role on the profitability for pharmaceutical firms.
Keywords: Greek pharmaceutical industry; R/D intensity; Competitiveness; Profitability; L1; L65 (search for similar items in EconPapers)
References: Add references at CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:spr:conchp:978-3-030-57517-5_3
Ordering information: This item can be ordered from
Access Statistics for this chapter
More chapters in Contributions to Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().